Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018 (2018), Article ID 4564328, 10 pages
https://doi.org/10.1155/2018/4564328
Research Article

STAT1, IGF1, RAC1, and MDM2 Are Associated with Recurrence of Giant Cell Tumor of Bone

1Department of Orthopedic Surgery, Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-sen University, Shantou 515041, China
2Department of Pathology, Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-sen University, Shantou 515041, China
3Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, China
4Institute of Oncologic Pathology, Shantou University Medical College, Shantou 515041, China

Correspondence should be addressed to Zhigang Zhong; moc.361@gzzts

Received 16 August 2017; Revised 8 November 2017; Accepted 28 November 2017; Published 31 January 2018

Academic Editor: Qing Lin

Copyright © 2018 Shuxin Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Raskin, J. H. Schwab, H. J. Mankin, D. S. Springfield, and F. J. Hornicek, “Giant cell tumor of bone,” Journal of the American Academy of Orthopaedic Surgeons, vol. 21, no. 2, pp. 118–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Wülling, C. Engels, N. Jesse, M. Werner, G. Delling, and E. Kaiser, “The nature of giant cell tumor of bone,” Journal of Cancer Research and Clinical Oncology, vol. 127, no. 8, pp. 467–474, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Chakarun, D. M. Forrester, C. J. Gottsegen, D. B. Patel, E. A. White, and G. R. Matcuk Jr, “Giant cell tumor of bone: review, mimics, and new developments in treatment,” Radiographics, vol. 33, no. 1, pp. 197–211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Levav-Cohen, Z. Goldberg, K. H. Tan et al., “The p53-Mdm2 loop: a critical juncture of stress response,” in Subcellular Biochemistry, vol. 85, pp. 161–186, Springer, Dordrecht, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. L. T. Chow, “Giant cell rich osteosarcoma revisited—diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment,” Virchows Archiv, vol. 468, no. 6, pp. 741–755, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Reckenbeil, D. Kraus, H. Stark et al., “Insulin-like growth factor 1 (IGF1) affects proliferation and differentiation and wound healing processes in an inflammatory environment with p38 controlling early osteoblast differentiation in periodontal ligament cells,” Archives of Oral Biology, vol. 73, pp. 142–150, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Mazziotti, A. M. Formenti, R. A. Adler et al., “Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines,” Endocrine, vol. 54, no. 3, pp. 603–611, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Meissl, S. Macho-Maschler, M. Müller, and B. Strobl, “The good and the bad faces of STAT1 in solid tumours,” Cytokine, vol. 89, pp. 12–20, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Zou, X. Mao, J. Yin et al., “Emerging roles of RAC1 in treating lung cancer patients,” Clinical Genetics, vol. 91, no. 4, pp. 520–528, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Chen, C. Li, B. Wu et al., “Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors,” International Journal of Oncology, vol. 45, no. 3, pp. 1133–1142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Wu, C. Li, Z. Du et al., “Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma,” Scientific Reports, vol. 4, article 5403, 2014. View at Google Scholar
  12. G. Su, J. H. Morris, B. Demchak, and G. D. Bader, “Biological network exploration with Cytoscape 3,” Current Protocols in Bioinformatics, vol. 47, pp. 8.13.1–8.13.24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Guérin, J. Thariat, M. Ouali et al., “A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification,” Human Pathology, vol. 50, pp. 70–78, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Shaikh, W. F. Morano, J. Lee et al., “Emerging role of MDM2 as target for anti-cancer therapy: a review,” Annals of Clinical & Laboratory Science, vol. 46, no. 6, pp. 627–634, 2016. View at Google Scholar
  16. F. Jin, Y. Wang, X. Wang et al., “Bre enhances osteoblastic differentiation by promoting the Mdm2-mediated degradation of p53,” Stem Cells, vol. 35, no. 7, pp. 1760–1772, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Rajbhandari, W. C. Lin, B. L. Wehde, A. A. Triplett, and K. U. Wagner, “Autocrine IGF1 signaling mediates pancreatic tumor cell dormancy in the absence of oncogenic drivers,” Cell Reports, vol. 18, no. 9, pp. 2243–2255, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Wang, A. Menendez, C. Fong, H. Z. ElAlieh, W. Chang, and D. D. Bikle, “Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation,” Journal of Bone and Mineral Research, vol. 29, no. 8, pp. 1900–1913, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Feng, W. Zheng, Q. Tang et al., “Fludarabine inhibits STAT1-mediated up-regulation of caspase-3 expression in dexamethasone-induced osteoblasts apoptosis and slows the progression of steroid-induced avascular necrosis of the femoral head in rats,” Apoptosis, vol. 22, no. 8, pp. 1001–1012, 2017. View at Publisher · View at Google Scholar
  20. C. Seeliger, L. Schyschka, Z. Kronbach et al., “Signaling pathway STAT1 is strongly activated by IFN-β in the pathogenesis of osteoporosis,” European Journal of Medical Research, vol. 20, no. 1, p. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Xiao, T. Naganawa, E. Obugunde et al., “Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts,” Journal of Biological Chemistry, vol. 279, no. 26, pp. 27743–27752, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Geng, L. Gu, F. Ju et al., “MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1,” Journal of Cellular and Molecular Medicine, vol. 20, no. 9, pp. 1611–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Mendoza-Naranjo, A. El-Naggar, D. H. Wai et al., “ERBB4 confers metastatic capacity in Ewing sarcoma,” EMBO Molecular Medicine, vol. 5, no. 7, pp. 1087–1102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Al-Sukaini, F. J. Hornicek, Z. S. Peacock, L. B. Kaban, S. Ferrone, and J. H. Schwab, “Immune surveillance plays a role in locally aggressive giant cell lesions of bone,” Clinical Orthopaedics and Related Research, vol. 475, no. 12, pp. 3071–3081, 2017. View at Publisher · View at Google Scholar
  25. M. A. Al-Abbadi, M. J. Al-Yousef, M. M. Yousef, S. S. Sheikh, N. M. Almasri, and S. S. Amr, “CD10 and CD138 can be expressed in giant cell tumor of bone: an immunohistochemical study,” Avicenna Journal of Medicine, vol. 6, no. 3, pp. 69–74, 2016. View at Publisher · View at Google Scholar